Formononetin inhibits tumor growth by suppression of EGFR-Akt-Mcl-1 axis in non-small cell lung cancer

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, April 2020

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (65th percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

twitter: 3 X users
patent: 1 patent

reddit: 1 Redditor

Citations

dimensions_citation: 37 Dimensions

Readers on

mendeley: 20 Mendeley

Summary X Patents Reddit Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

COMBINATION THERAPY FOR THE TREATMENT OF CANCER COMPRISING AN ANTI-EGFR ANTIBODY AND AN…

Application WO-2022269605-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.